Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative ICG and MR Spectroscopic Imaging in CNS Tumors
NCT02710240Phase 2Completed
- Sponsor
- Abramson Cancer Center
- Start
- Jun 2015
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indocyanine green in central nervous system tumor, sponsored by Abramson Cancer Center. Started Jun 2015; status: completed.
02
Drugs
indocyanine green
03
Conditions
central nervous system tumor
Beyond the preview
Go deeper on NCT02710240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02710240.